Quimatryx

Updated: October 28, 2025

Laureano Simon - CEO

Country: Spain | Add Funding

Website: https://quimatryx.com

Quimatryx develops QTX125, a patented HDAC6 selective inhibitor for the treatment of pancreatic cancer.

Competitors